Australian PC manufacturer Pioneer Computers is aiming to cash in on the Internet of Things market with the release of Dreamcare Dr Glucose, a non-invasive glucose measurement system.
Pioneer general manager Jeff Li said there are 100 million people with glucose-related problems in China alone, a big opportunity for its PioneerIoT business.
Dreamcare Dr Glucose system is based on the metabolic heat conformation (MHC) method. MHC involves the measurement of physiologic indices related to body heat generation and local oxygen supply.
The device, which resembles a mouse, integrates sensors that collect information from a patient's fingertip. The internal circuit takes care of the data conversion and a microprocessor calculates the value of the parameters. The result is displayed on any personal device with the app provided, compatible with iOS and Android.
The process takes 60 seconds and is 88.4 percent accurate compared against an Autolab 18 automatic biochemical analyser blood glucose, according to PioneerIoT, the most used product in the bigger test labs and hospitals with 99 percent accuracy.
According to Li, investing in the health market is part of the company’s growth plan for the next 10 years.
Li said the target market extends from home users to clinics and hospitals, because the product is very simple to use and there is no need for blood samples.
Dreamcare is already available for buy directly from the website or via partners who will get rebates from the sales.
Li added that PioneerIoT has received enquiries about the product from China, Japan, US and Europe.